Key facts
- It has raised $1.3M across 1 recorded rounds; the latest was Equity Crowdfunding ($10K) in Feb 2026.
- Notable investors include U.S. Department of Energy, StartX (US), Keiretsu Forum, IHH Healthcare, K2X — 6 tracked in total.
- TibaRay has filed 1 Form D with the SEC, most recently May 2025 ($1.3M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for TibaRay
Funding rounds
1 roundsAbout TibaRay
Developer of healthcare devices designed to create technologies to cure patients with all types and stages of cancer. The company offers radiation therapy, motion-freezing precision, conformal photons, CT imaging, and accelerators, enabling healthcare industries with novel linear accelerators, RF sources, and components.
- Sector
- Healthcare
- HQ
- Fremont, CA, United States
- Founded
- 2014
- Employees
- 16
- Website
- tibaray.com/
- Ownership
- Privately Held (backing)
TibaRay doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TibaRay shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TibaRay in its N-PORT filings yet. We sweep new filings monthly.